WallStSmart
SHPH

Shuttle Pharmaceuticals Inc

NASDAQ: SHPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.68
-7.82% today

Updated 2026-06-05

Market cap
$2.66M
P/E ratio
45.40
P/S ratio
EPS (TTM)
$0.01
Dividend yield
52W range
$0 – $6
Volume
1.7M

Shuttle Pharmaceuticals Inc (SHPH) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2015201620172018202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$18739.00$18000.00$54951.00$60834.00$5972.00$6811.00$5463.00$290107.00
Gross profit$-18739.00$-18000.00$-54951.00$-60834.00$-5972.00$-6811.00$-5463.00$-290107.00
Gross margin
R&D$836.00$55572.00$161772.00$1.02M$1.05M$3.52M$3.62M$4.05M
SG&A$347750.00$721184.00$1.07M$2.38M$4.08M$7.86M
Operating income$-203890.00$-586630.00$-509522.00$-1.74M$-2.34M$-5.89M$-7.70M$-11.92M
Operating margin
EBITDA$-183971.00$-577223.00$-711151.00$-1.04M$-4.32M$-3.99M$-7.78M$-11.36M
EBITDA margin
EBIT$-291659.00$-336156.00$-202710.00$-595223.00$-766102.00$-1.10M$-4.33M$-4.00M$-7.78M$-11.65M
Interest expense$0.00$0.00$10881.00$30916.00$39630.00$50788.00$670610.00$2.60M$1.36M$70828.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-213594.00$-626139.00$-805732.00$-1.15M$-5.00M$-6.59M$-9.14M$-11.72M
Net income growth (YoY)-193.1%-28.7%-43.0%-333.6%-32.0%-38.7%-28.2%
Profit margin

Frequently asked questions

How much free cash flow does SHPH generate?

SHPH produced $-9.48M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is SHPH's balance sheet healthy?

SHPH holds $334005.00 in cash and equivalents against — in long-term debt, on $2.25M of shareholder equity. That debt is best read against the cash flow the business throws off each year.